CONTEXT: In recent years, an association has been noted between several abnormalities that characterize the metabolic syndrome (MetS) and primary hyperparathyroidism (pHPT). These abnormalities include dyslipidaemia, obesity, insulin resistance and hypertension. The correlations between plasma calcium, parathyroid hormone (PTH) and the variables in the MetS in a normal population are still unclear. OBJECTIVE: To describe correlations between plasma calcium and PTH and the various abnormalities present in the MetS in a healthy population. DESIGN: We studied 1016 healthy individuals from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) population of 70 years old, by means of plasma analyses of calcium, PTH, creatinine, lipids, insulin and glucose, as well as by standardized blood pressure measurements. Further, body mass index (BMI) and waist circumference were determined. RESULTS: The more National Cholesterol Education Program (NCEP) criteria for the MetS that were met, the higher the s-PTH and albumin-corrected s-calcium. Further, positive correlations between plasma calcium and BMI (P = 0.0003), waist circumference (P = 0.0009) and insulin resistance (P = 0.079) were found. PTH and BMI (P < 0.0001), waist circumference (P < 0.0001), systolic blood pressure (P = 0.0034), diastolic blood pressure (P = 0.0008), serum triglycerides (P = 0.0003) and insulin resistance (P = 0.0003) were positively correlated, whereas serum high density lipoproteins (HDL) (P = 0.036) and PTH were negatively correlated. CONCLUSIONS: We conclude that PTH correlates with several of the metabolic factors included in the MetS within a normocalcaemic population. In addition, individuals with mild pHPT present significantly more NCEP criteria for MetS. We postulate that increased levels of PTH in pHPT may be associated with the increased cardiovascular morbidity and mortality seen in pHPT.
CONTEXT: In recent years, an association has been noted between several abnormalities that characterize the metabolic syndrome (MetS) and primary hyperparathyroidism (pHPT). These abnormalities include dyslipidaemia, obesity, insulin resistance and hypertension. The correlations between plasma calcium, parathyroid hormone (PTH) and the variables in the MetS in a normal population are still unclear. OBJECTIVE: To describe correlations between plasma calcium and PTH and the various abnormalities present in the MetS in a healthy population. DESIGN: We studied 1016 healthy individuals from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) population of 70 years old, by means of plasma analyses of calcium, PTH, creatinine, lipids, insulin and glucose, as well as by standardized blood pressure measurements. Further, body mass index (BMI) and waist circumference were determined. RESULTS: The more National Cholesterol Education Program (NCEP) criteria for the MetS that were met, the higher the s-PTH and albumin-corrected s-calcium. Further, positive correlations between plasma calcium and BMI (P = 0.0003), waist circumference (P = 0.0009) and insulin resistance (P = 0.079) were found. PTH and BMI (P < 0.0001), waist circumference (P < 0.0001), systolic blood pressure (P = 0.0034), diastolic blood pressure (P = 0.0008), serum triglycerides (P = 0.0003) and insulin resistance (P = 0.0003) were positively correlated, whereas serum high density lipoproteins (HDL) (P = 0.036) and PTH were negatively correlated. CONCLUSIONS: We conclude that PTH correlates with several of the metabolic factors included in the MetS within a normocalcaemic population. In addition, individuals with mild pHPT present significantly more NCEP criteria for MetS. We postulate that increased levels of PTH in pHPT may be associated with the increased cardiovascular morbidity and mortality seen in pHPT.
Authors: Veronika Fedirko; Elio Riboli; H Bas Bueno-de-Mesquita; Sabina Rinaldi; Tobias Pischon; Teresa Norat; Eugène H J M Jansen; Fränzel J B van Duijnhoven; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Pierre Engel; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Brian Buijsse; Antonia Trichopoulou; Dimitrios Trichopoulos; Pagona Lagiou; Sabina Sieri; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Carla H van Gils; Petra H M Peeters; Maria-Dolores Chirlaque; Aurelio Barricarte Gurrea; Laudina Rodríguez; Esther Molina-Montes; Miren Dorronsoro; Catalina Bonet; Richard Palmqvist; Göran Hallmans; Timothy J Key; Konstantinos K Tsilidis; Kay-Tee Khaw; Isabelle Romieu; Kurt Straif; Petra A Wark; Dora Romaguera; Mazda Jenab Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-03-04 Impact factor: 4.254
Authors: Georges Saab; Adam Whaley-Connell; Andrew Bombeck; Manjula Kurella Tamura; Suying Li; Shu-Cheng Chen; Samy I McFarlane; James R Sowers; Keith Norris; George L Bakris; Peter A McCullough Journal: Cardiorenal Med Date: 2011-04-15 Impact factor: 2.041
Authors: Peggy M Cawthon; Neeta Parimi; Elizabeth Barrett-Connor; Gail A Laughlin; Kristine E Ensrud; Andrew R Hoffman; James M Shikany; Jane A Cauley; Nancy E Lane; Douglas C Bauer; Eric S Orwoll; Steven R Cummings Journal: J Clin Endocrinol Metab Date: 2010-07-14 Impact factor: 5.958
Authors: Ellen L de Hollander; Wanda Je Bemelmans; Hendriek C Boshuizen; Nele Friedrich; Henri Wallaschofski; Pilar Guallar-Castillón; Stefan Walter; M Carola Zillikens; Annika Rosengren; Lauren Lissner; Julie K Bassett; Graham G Giles; Nicola Orsini; Noor Heim; Marjolein Visser; Lisette Cpgm de Groot Journal: Int J Epidemiol Date: 2012-03-31 Impact factor: 7.196